A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 2473111)

Published in J Immunol on August 01, 1989

Authors

Y St-Pierre1, N Nabavi, Z Ghogawala, L H Glimcher, T H Watts

Author Affiliations

1: Department of Immunology, University of Toronto, Ontario, Canada.

Articles citing this

Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31

Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med (1995) 1.17

Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci U S A (1996) 0.91

Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules. J Exp Med (1994) 0.87

CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med (1994) 0.87

Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles. Immunogenetics (2004) 0.86

Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes. Proc Natl Acad Sci U S A (1996) 0.82

High copy number I-Ab transgenes induce production of IgE through an interluekin 4-dependent mechanism. Proc Natl Acad Sci U S A (1996) 0.79

Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation. J Exp Med (1993) 0.79

Interaction of a nuclear protein with a palindromic sequence of the mouse immunoglobulin lambda 2-chain gene promoter is important for its transcription. Mol Cell Biol (1990) 0.77

Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines. Immunology (1993) 0.75

Articles by these authors

A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61

Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72

Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88

Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99

The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13

Supported planar membranes in studies of cell-cell recognition in the immune system. Biochim Biophys Acta (1986) 4.83

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48

The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med (2002) 4.47

An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17

The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14

The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med (1995) 3.18

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07

Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01

A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (1990) 2.83

Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci U S A (1984) 2.80

c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med (1998) 2.58

Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (1992) 2.55

Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature (1996) 2.50

Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity (1994) 2.40

Transcriptional regulation of Th1/Th2 polarization. Immunol Today (2000) 2.39

NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity (2001) 2.38

mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol Cell Biol (1990) 2.38

A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol (2000) 2.33

Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A (1993) 2.18

Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity (1998) 2.16

The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity (1998) 2.13

Biochemical studies on pili isolated from Pseudomonas aeruginosa strain PAO. Can J Microbiol (1979) 2.08

Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A (1993) 2.03

In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science (1991) 2.02

Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity (1998) 2.00

1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol (1984) 1.97

Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J Exp Med (1996) 1.95

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol (2001) 1.90

Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol (1995) 1.89

T-cell-mediated association of peptide antigen and major histocompatibility complex protein detected by energy transfer in an evanescent wave-field. Nature (1986) 1.88

Spectral properties of three quaternary arrangements of Pseudomonas pilin. Biochemistry (1983) 1.86

The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86

The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core. Nucleic Acids Res (1996) 1.83

Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity (1995) 1.82

Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (1996) 1.82

MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int (1990) 1.77

IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76

Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity (2000) 1.74

Mapping of the antigenic determinants of Pseudomonas aeruginosa PAK polar pili. Infect Immun (1983) 1.73

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1993) 1.72

Antigen presentation abrogated in cells expressing truncated Ia molecules. J Immunol (1989) 1.71

Production of autoreactive I region-restricted T cell hybridomas. J Exp Med (1982) 1.70

In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum (1991) 1.66

Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65

The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med (2000) 1.63

High-affinity fluorescent peptide binding to I-Ad in lipid membranes. Proc Natl Acad Sci U S A (1986) 1.61

Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans. Infect Immun (1986) 1.61

Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61

Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61

Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci U S A (1999) 1.60

Structure of polar pili from Pseudomonas aeruginosa strains K and O. J Mol Biol (1981) 1.59

Costimulation of CD28- T lymphocytes by 4-1BB ligand. J Immunol (1997) 1.59

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med (1985) 1.57

Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J Exp Med (1993) 1.57

A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J (1994) 1.56

CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med (1998) 1.54

Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc Natl Acad Sci U S A (1991) 1.52

Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells. Kidney Int (1993) 1.50

Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun (1991) 1.48

I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature (1982) 1.48

Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol (1990) 1.48

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J Exp Med (1995) 1.45

Cloning of an interleukin-4 inducible gene from cytotoxic T lymphocytes and its identification as a lipase. Cell (1990) 1.44

A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol Cell Biol (1990) 1.43

B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol (1996) 1.43

Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol (1996) 1.43

Differences in DNA sequence specificity among MHC class II X box binding proteins. J Immunol (1989) 1.42

T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med (1981) 1.40

Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40

T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentation. Proc Natl Acad Sci U S A (1985) 1.39

In situ hybridization studies suggest a role for the basic region-leucine zipper protein hXBP-1 in exocrine gland and skeletal development during mouse embryogenesis. Dev Dyn (1993) 1.39

Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem (1999) 1.39

Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity (1995) 1.38

Complex regulation of class II gene expression: analysis with class II mutant cell lines. J Immunol (1985) 1.36

Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol (1999) 1.36

The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J Immunol (1980) 1.36

Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules. J Exp Med (1983) 1.35

Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int (1991) 1.35

Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element. Science (1988) 1.34

Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J Immunol (1983) 1.33

Dissociation and characterization of pilin isolated from Pseudomonas aeruginosa strains PAK and PAO. Can J Biochem (1982) 1.32

Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31

Identification of pilin pools in the membranes of Pseudomonas aeruginosa. J Bacteriol (1982) 1.31

In vitro binding of natural killer cells to Cryptococcus neoformans targets. Infect Immun (1985) 1.30

Expression of the T-cell-specific gamma gene is unnecessary in T cells recognizing class II MHC determinants. Nature (1985) 1.29

Direct evidence that a class II molecule and a simple globular protein generate multiple determinants. J Exp Med (1985) 1.29